1.Cytotoxic effects of the novel photosensitizer PEG-MTPABZ-PyC-mediated photodynamic therapy on gastric cancer cells.
Lingjuan CHEN ; Qi WANG ; Lu WANG ; Yifei SHEN ; Haibin WANG ; Hengxin WANG ; Xuejie SU ; Meixu LEI ; Xianxia CHEN ; Chengjin AI ; Yifan LI ; Yali ZHOU
Journal of Central South University(Medical Sciences) 2025;50(7):1137-1144
OBJECTIVES:
The application of photodynamic therapy in solid tumors has attracted increasing attention in recent years, and the efficiency of photosensitizers is a crucial determinant of therapeutic efficacy. This study aims to evaluate the cytotoxic effects of a novel photosensitizer, PEG-MTPABZ-PyC, in photodynamic therapy against gastric cancer cells.
METHODS:
Gastric cancer MKN45 cells were treated with PEG-MTPABZ-PyC. A high-content live-cell imaging system was used to assess the cellular uptake kinetics and subcellular localization of the photosensitizer. The cytotoxic effects of PEG-MTPABZ-PyC-mediated photodynamic therapy were examined using the cell counting kit-8 (CCK-8) assay and flow cytometry, while the intrinsic cytotoxicity of the photosensitizer alone was verified by the CCK-8 assay. Intracellular reactive oxygen species (ROS) generation after photodynamic therapy was detected using 2'-7'-dichlorodihydrofluorescein diacetate (DCFH-DA).
RESULTS:
PEG-MTPABZ-PyC alone exhibited no cytotoxicity toward MKN45 cells, indicating excellent cytocompatibility. The compound efficiently entered cells within 6 hours and localized predominantly in lysosomes. Upon light irradiation, PEG-MTPABZ-PyC-mediated photodynamic therapy induced significant cytotoxicity compared with the control group (P<0.05) and generated abundant intracellular ROS.
CONCLUSIONS
The novel photosensitizer PEG-MTPABZ-PyC demonstrates potent photodynamic cytotoxicity against gastric cancer cells, showing promising potential for further development in gastric cancer photodynamic therapy.
Humans
;
Stomach Neoplasms/drug therapy*
;
Photochemotherapy/methods*
;
Photosensitizing Agents/pharmacology*
;
Cell Line, Tumor
;
Polyethylene Glycols/chemistry*
;
Reactive Oxygen Species/metabolism*
;
Mesoporphyrins/pharmacology*
2.Exploring the medication patterns of traditional Chinese medicine in the treatment of presbycusis based on data mining and network pharmacology
Lanyi QIN ; Yiqun WEN ; Lingjuan LU
China Modern Doctor 2025;63(25):72-78
Objective To explore the medication patterns as well as the potential mechanism of action of traditional Chinese medicine in the treatment of presbycusis based on data mining and network pharmacology.Methods Search for the literatures on the treatment of presbycusis with traditional Chinese medicine in CNKI,Wanfang Data Knowledge Service Platform and VIP,conduct visual analyses such as association rule analysis and cluster analysis on them,and summarize the medication patterns and core drug combinations.Predict the action targets of drugs and diseases through network pharmacology,and obtain core targets and pathways.Results A total of 22 literatures were included,and 22 traditional Chinese medicine prescriptions were obtained,involving 72 kinds of traditional Chinese medicines,with a total frequency of administration of 238 times.The four natures of the medicine were mainly warm,the five flavors were mainly sweet,bitter and pungent,and channel tropism were mainly liver meridian and kidney meridian.The core drug combination was Shanzhuyu and Shudihuang.Network pharmacological analysis showed that this combination may improve presbycusis by influencing core targets such as protein kinase B(Akt)1 and interleukin-6,thereby intervening in related pathways such as advanced glycation end product/advanced glycation end product receptor signaling pathway and the phosphoinositide 3-kinase/Akt signaling pathway.Conclusion The treatment of presbycusis with traditional Chinese medicine mainly focuses on invigorating kidney for consolidating semen,while also circulate and nourish blood.Network pharmacology predicts the key mechanisms of core high-frequency drug treatment for presbycusis,providing data support and theoretical basis for the clinical treatment of traditional Chinese medicine.
3.Exploring the medication patterns of traditional Chinese medicine in the treatment of presbycusis based on data mining and network pharmacology
Lanyi QIN ; Yiqun WEN ; Lingjuan LU
China Modern Doctor 2025;63(25):72-78
Objective To explore the medication patterns as well as the potential mechanism of action of traditional Chinese medicine in the treatment of presbycusis based on data mining and network pharmacology.Methods Search for the literatures on the treatment of presbycusis with traditional Chinese medicine in CNKI,Wanfang Data Knowledge Service Platform and VIP,conduct visual analyses such as association rule analysis and cluster analysis on them,and summarize the medication patterns and core drug combinations.Predict the action targets of drugs and diseases through network pharmacology,and obtain core targets and pathways.Results A total of 22 literatures were included,and 22 traditional Chinese medicine prescriptions were obtained,involving 72 kinds of traditional Chinese medicines,with a total frequency of administration of 238 times.The four natures of the medicine were mainly warm,the five flavors were mainly sweet,bitter and pungent,and channel tropism were mainly liver meridian and kidney meridian.The core drug combination was Shanzhuyu and Shudihuang.Network pharmacological analysis showed that this combination may improve presbycusis by influencing core targets such as protein kinase B(Akt)1 and interleukin-6,thereby intervening in related pathways such as advanced glycation end product/advanced glycation end product receptor signaling pathway and the phosphoinositide 3-kinase/Akt signaling pathway.Conclusion The treatment of presbycusis with traditional Chinese medicine mainly focuses on invigorating kidney for consolidating semen,while also circulate and nourish blood.Network pharmacology predicts the key mechanisms of core high-frequency drug treatment for presbycusis,providing data support and theoretical basis for the clinical treatment of traditional Chinese medicine.
4.Design and development of brain and heart health management mini-program
Huanhuan HU ; Jing ZHENG ; Xiaoying LU ; Lingjuan ZHANG ; Dongmei LI
Chinese Journal of Modern Nursing 2024;30(14):1851-1856
Objective:To design and develop a WeChat mini-program for risk assessment and health management of people at high-risk of stroke.Methods:Relying on the network platforms and smartphones, a WeChat mini-program based health management network platform was designed and developed based on the analysis of the needs of high-risk stroke populations and medical staff for the management of high-risk stroke populations, with health data collection, stroke risk assessment, health education and knowledge base matching and intervention programs and data privacy and security as the key technologies.Results:The mini-program included three ports, such as the patient end, medical staff end and backend management end. It had the main functions of stroke risk assessment, intelligent promotion of health management follow-up plans, recording of health indicators and medication reminders, interactive consultation, and health knowledge promotion.Conclusions:The development of risk assessment and health management WeChat mini-program for high-risk stroke populations and the use of a simple and effective intelligent assessment to realize rapid classification of stroke risk in population lay a foundation for the WeChat mini-program function module to carry out individualized, accurate and efficient brain-heart health management.
5.The protective effect of cGAS/STING/IFN-Ⅰ signaling pathway mediating endothelial progenitor cells on atherosclerosis associated with systemic lupus erythematosus
Qiuyu LIN ; Siyi HE ; Lingjuan LIU ; Peng HUANG ; Lu ZHANG ; Sisi TAO ; Zhiquan XU ; Yi REN ; Shuanghong MO ; Hongai LI ; Wei XIANG ; Xiaojie HE
Journal of Chinese Physician 2024;26(12):1766-1772
Objective:To study the inhibitory effect of endothelial progenitor cells (EPCs) on aortic injury in mice with systemic lupus erythematosus (SLE) arteriosclerosis.Methods:APOE -/- mice were injected with norphytane and high fat diet to establish lupus vascular injury model. Then the mice were divided into normal control group (ND group), high fat diet group (HFD group), high fat diet+ SLE vascular injury group (HFD+ SLE group), high fat diet+ SLE vascular injury+ hydroxychloroquine treatment group (HFD+ SLE+ Hydro group), high fat diet+ SLE vascular injury+ EPCs treatment group (HFD+ SLE+ EPCs group). At the end of the experiment, urine, blood and aortic tissues of mice in each group were collected, and the content of urinary protein and the depth of serum type I interferon (IFN-Ⅰ) were detected by enzyme linked immunosorbent assay (ELISA). The activation of cyclic guanosine monophosphate synthase/interferon gene stimulating factor/type I interferon (cGAS/STING/IFN-Ⅰ) pathway, the levels of inflammatory factors, adhesion fractions and chemokines in the aorta of mice in each group were detected by immunohistochemistry and Western blotting (WB). The lipid deposition in the aorta was detected by oil red staining. Results:The results of ELISA showed that the levels of urinary protein and serum IFN-Ⅰ in HFD+ SLE group were higher than those in normal control group. EPCs treatment could reduce the levels of urinary protein and serum IFN-Ⅰ in SLE atherosclerotic mice. WB results showed that the expression of CD19, CD68, CD34, chemokine, cGAS, p-STING, phosphorylated TANK binding kinase 1 (p-TBK1), phosphorylated interferon regulatory factor 3 (p-IRF3) and IFN-Ⅰ increased in HFD+ SLE group, and hydroxychloroquine and EPCs decreased the levels of these factors. CGAS/STING/IFN-Ⅰ signal pathway is involved in the occurrence and development of atherosclerosis in SLE patients; both EPCs and hydroxychloroquine can inhibit the activation of cGAS/STING/IFN-Ⅰ signal, thus reducing atherosclerosis in SLE mice.Conclusions:cGAS/STING/IFN-Ⅰ pathway is involved in the development of SLE atherosclerosis. EPCs can inhibit the activation of cGAS/STING signal, reduce the expression and secretion of IFN-Ⅰ, and then reduce vascular inflammation and inhibit the development of SLE-related atherosclerosis.
6.The protective effect of cGAS/STING/IFN-Ⅰ signaling pathway mediating endothelial progenitor cells on atherosclerosis associated with systemic lupus erythematosus
Qiuyu LIN ; Siyi HE ; Lingjuan LIU ; Peng HUANG ; Lu ZHANG ; Sisi TAO ; Zhiquan XU ; Yi REN ; Shuanghong MO ; Hongai LI ; Wei XIANG ; Xiaojie HE
Journal of Chinese Physician 2024;26(12):1766-1772
Objective:To study the inhibitory effect of endothelial progenitor cells (EPCs) on aortic injury in mice with systemic lupus erythematosus (SLE) arteriosclerosis.Methods:APOE -/- mice were injected with norphytane and high fat diet to establish lupus vascular injury model. Then the mice were divided into normal control group (ND group), high fat diet group (HFD group), high fat diet+ SLE vascular injury group (HFD+ SLE group), high fat diet+ SLE vascular injury+ hydroxychloroquine treatment group (HFD+ SLE+ Hydro group), high fat diet+ SLE vascular injury+ EPCs treatment group (HFD+ SLE+ EPCs group). At the end of the experiment, urine, blood and aortic tissues of mice in each group were collected, and the content of urinary protein and the depth of serum type I interferon (IFN-Ⅰ) were detected by enzyme linked immunosorbent assay (ELISA). The activation of cyclic guanosine monophosphate synthase/interferon gene stimulating factor/type I interferon (cGAS/STING/IFN-Ⅰ) pathway, the levels of inflammatory factors, adhesion fractions and chemokines in the aorta of mice in each group were detected by immunohistochemistry and Western blotting (WB). The lipid deposition in the aorta was detected by oil red staining. Results:The results of ELISA showed that the levels of urinary protein and serum IFN-Ⅰ in HFD+ SLE group were higher than those in normal control group. EPCs treatment could reduce the levels of urinary protein and serum IFN-Ⅰ in SLE atherosclerotic mice. WB results showed that the expression of CD19, CD68, CD34, chemokine, cGAS, p-STING, phosphorylated TANK binding kinase 1 (p-TBK1), phosphorylated interferon regulatory factor 3 (p-IRF3) and IFN-Ⅰ increased in HFD+ SLE group, and hydroxychloroquine and EPCs decreased the levels of these factors. CGAS/STING/IFN-Ⅰ signal pathway is involved in the occurrence and development of atherosclerosis in SLE patients; both EPCs and hydroxychloroquine can inhibit the activation of cGAS/STING/IFN-Ⅰ signal, thus reducing atherosclerosis in SLE mice.Conclusions:cGAS/STING/IFN-Ⅰ pathway is involved in the development of SLE atherosclerosis. EPCs can inhibit the activation of cGAS/STING signal, reduce the expression and secretion of IFN-Ⅰ, and then reduce vascular inflammation and inhibit the development of SLE-related atherosclerosis.
7.Construction of evaluation criteria for long-term care ability of the elderly
Jing LIU ; Xiaoying LU ; Jianling HAO ; Wenyao CHEN ; Yanqiu WENG ; Lingjuan ZHANG
Chinese Journal of Modern Nursing 2023;29(2):165-169
Objective:To explore the construction of evaluation criteria for long-term care ability of the elderly suitable for China's national conditions.Methods:The evaluation criteria were initially established through literature research and field semi-structured interviews. Through the Delphi method, 15 experts were consulted and the evaluation criteria for the long-term care ability of the elderly were finally established.Results:The effective rate of the two rounds of expert consultation questionnaires was 100%, and the expert authority coefficients were 0.91 and 0.92 respectively. The evaluation criteria for long-term care ability of the elderly were established, including two first-level indicators of self-care ability and disease severity, four second-level indicators of abilities of daily living, mental state and social participation, perception and communication, and disease severity, as well as 39 third-level indicators including recumbent status, cognitive function, level of consciousness, illness and so on.Conclusions:The evaluation criteria for long-term care ability of the elderly are scientific and reliable, which can provide a reference for the classification of long-term care services for the disabled elderly in China.
8.Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions.
Leilei FU ; Wenke JIN ; Jiahui ZHANG ; Lingjuan ZHU ; Jia LU ; Yongqi ZHEN ; Lan ZHANG ; Liang OUYANG ; Bo LIU ; Haiyang YU
Acta Pharmaceutica Sinica B 2022;12(2):532-557
Drug repurposing or repositioning has been well-known to refer to the therapeutic applications of a drug for another indication other than it was originally approved for. Repurposing non-oncology small-molecule drugs has been increasingly becoming an attractive approach to improve cancer therapy, with potentially lower overall costs and shorter timelines. Several non-oncology drugs approved by FDA have been recently reported to treat different types of human cancers, with the aid of some new emerging technologies, such as omics sequencing and artificial intelligence to overcome the bottleneck of drug repurposing. Therefore, in this review, we focus on summarizing the therapeutic potential of non-oncology drugs, including cardiovascular drugs, microbiological drugs, small-molecule antibiotics, anti-viral drugs, anti-inflammatory drugs, anti-neurodegenerative drugs, antipsychotic drugs, antidepressants, and other drugs in human cancers. We also discuss their novel potential targets and relevant signaling pathways of these old non-oncology drugs in cancer therapies. Taken together, these inspiring findings will shed new light on repurposing more non-oncology small-molecule drugs with their intricate molecular mechanisms for future cancer drug discovery.
9.Willingness of influenza vaccination among the communitymanaged diabetic patients in Keqiao District
CHEN Xiangyu ; FANG Le ; LU Feng ; GUO Lihua ; XU Chunxiao ; SHEN Diaoying ; FU Lingjuan ; ZHONG Jieming
Journal of Preventive Medicine 2020;32(11):1111-1114
Objective:
To learn the willingness and influencing factors of influenza vaccination among the community managed diabetic patients in Keqiao District, Shaoxing, so as to provide the basis for influenza vaccination promotion.
Methods:
A self-compiled questionnaire survey was conducted from October to December 2017 among all the managed diabetic patients in Keqiao District. The contents of questionnaire included the basic information of the respondents, awareness of influenza vaccine, vaccination status and vaccination intention. Logistic regression model was used to analyze the influencing factors for the willingness of influenza vaccination.
Results:
A total of 15 060 questionnaires were sent out and 13 781 valid ones were retrieved, the response rate was 91.51%. There were 3 888 patients with the awareness of influenza vaccine, accounting for 28.21%; 4 259 patients with the willingness to be vaccinated, accounting for 30.90%; 630 previously-vaccinated patients, accounting for 4.57%. The patients who were female (OR=1.157, 95%CI: 1.064-1.258) , were married (OR=1.242, 95%CI:1.107-1.393), were with other chronic diseases (OR=1.199, 95%CI: 1.103-1.303) , believed diabetic patients were more susceptible to influenza (OR=1.251, 95%CI: 1.102-1.419) , believed influenza aggravate diabetes status (OR=1.640, 95%CI: 1.445-1.860) , believed that the vaccination effectively prevent influenza (OR=3.129, 95%CI: 2.866-3.416) , knew about influenza vaccine (OR=1.111, 95%CI: 1.105-1.216) and ever received influenza vaccination (OR=1.316, 95%CI: 1.103-1.570) were more willing to be vaccinated.
Conclusions
The willingness of influenza vaccination among the community managed diabetic patients in Keqiao District is low. The patients'gender, married status, other chronic diseases, awareness of influenza vaccine and the history of vaccination can affect the willingness of influenza vaccination.
10.Position and responsibilities of stroke emergency specialist nurses: a qualitative study
Yanqiu WENG ; Lingjuan ZHANG ; Dong RAO ; Xiaoying LU ; Huohong QIAN ; Min HU ; Dongmei LI ; Longjuan YU
Chinese Journal of Modern Nursing 2019;25(21):2645-2648
[Abstract]? Objective? To explore the position and responsibilities of stroke emergency specialist nurses. Methods? The interviewing method in qualitative studies was adopted and in-depth semi-structured interviews were conducted on four doctors, four nurses, two technicians and six managers. Claizzi's seven-step phenomenological data analysis method was used to encode, assemble, categorize, analyze and refine the content theme. Results? The position of stroke emergency specialist nurses is compound specialist and team coordinator. Its duties include accurate identification of stroke patients, early warning for CT room and rapid preparation before thrombolysis, assisting family members in clinical decision-making, ensuring seamless connection of all steps, handing over with rescue room and digital subtraction angiography (DSA) room and ward, ensuring adequate material supply, establishing and maintaining database and continuing patient return visit. Conclusions? The post setting of stroke emergency specialist nurses laid a foundation for the rapid treatment of stroke patients. Their role was positioned as senior practical nurses, and their post setting faced a series of challenges. Promoting the mature experience of post setting of stroke emergency specialist nursess can train a group of stroke emergency specialist nursess and lead the development of specialized stroke nursing.


Result Analysis
Print
Save
E-mail